Large Trial for Metrogel 1% Competitor

Written by on March 27, 2015 in clinical trials, Metrogel 1%, prescriptions with 0 Comments

A clinical research company has posted a large clinical trial to compare a Metronidazole 1% Gel to Galderma’s Metrogel 1%.

The multi center trial is looking for 947 participants across the US.

The manufacturer of the comparison Metronidazole 1% Gel is not mentioned, but a reasonable guess would be Metronidazole Gel from Sandoz.

Generic Metronidazole 1% is available in the US from Sandoz, but scant reviews are available online.

This is good news for rosacea sufferers looking and hoping for a more affordable Metronidazole 1% Gel.

Clinical Trial NCT02393937

A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea

The purpose of this study is to compare the efficacy of two Metronidazole Gels 1%, in the treatment of Rosacea.

Sponsor: bioRASI, LLC

Primary Outcome Measures:

  • To compare the test and reference products of metronidazole topical gel 1% with regard to the mean percent change from Baseline of the inflammatory lesion counts of rosacea. [ Time Frame: 70 Days ]

Estimated Enrollment: 947

Study Start Date: February 2015

Estimated Primary Completion Date: July 2015

Participants are assigned to one of three groups in parallel for the duration of the study

Experimental: Metronidazole Gel 1%

Drug: Metronidazole Gel 1%,  Metrogel 1% Galderma S.A., and Placebo Gel.

Related Articles

About the Author

About the Author: David Pascoe started the Rosacea Support Group in October 1998. .

Follow Rosacea Support

Subscribe via RSS Feed

Leave your comment here


Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.